| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/10/1992 | CA2060937A1 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation |
| 08/08/1992 | CA2060771A1 Nitrogenated bicyclic derivatives substitutes by a benzyl radical, process for their preparation, novel intermediates thus obtaines, their applications as drugs, and pharmaceutical compositions containing them |
| 08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
| 08/05/1992 | EP0497629A1 Heterocyclic amido prostaglandin analogs |
| 08/05/1992 | EP0497085A1 Heterocyclic ketone prostaglandin analogs |
| 08/05/1992 | EP0496858A1 Pharmaceutical compositions with mucolytic and antitussive activity containing (-)-trans-sobrerol |
| 08/05/1992 | EP0496746A1 Pharmaceutically active amino-substituted heteroaryl amines |
| 08/05/1992 | EP0261185B1 7-oxoprostacycline derivatives and process for their manufacture |
| 08/05/1992 | CN1017707B Process for preparation of new thiazole compounds |
| 08/04/1992 | US5135939 Treating thermobotic and vasospastic disease |
| 08/04/1992 | US5135938 Leukotriene antagonists |
| 08/02/1992 | CA2059906A1 Heterocyclic amido prostaglandin analogs |
| 08/01/1992 | WO1992013545A1 Endothelin converting enzyme inhibitors |
| 08/01/1992 | CA2100171A1 Endothelin converting enzyme inhibitors |
| 07/30/1992 | CA2035143A1 Compositions with enhanced penetration |
| 07/29/1992 | EP0496452A1 Novel endothelin receptor antagonists isolated from microbispora |
| 07/29/1992 | EP0496238A1 Substituted benzoxazepines and benzothiazepines, process for their preparation and their use as medicaments |
| 07/29/1992 | EP0496237A2 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept[b]indole |
| 07/29/1992 | EP0496138A1 Atropine-salbutamol aerosol |
| 07/29/1992 | EP0496013A1 Synthetic peptide derived from human lipocortin V and use thereof |
| 07/29/1992 | CN1063108A Trifluoromethylktone derivatives and processes for preparation thereof and use thereof |
| 07/29/1992 | CN1063100A Heterocyclic compounds |
| 07/29/1992 | CA2057546A1 Heterocyclic ketone prostaglandin analogs |
| 07/28/1992 | US5134151 Platelet Activating Factor Antagonist |
| 07/28/1992 | CA1305713C (d) and (l)-3-(amino-methyl)-2-methanol-7-oxabicyclo¬2.2.1| heptane |
| 07/28/1992 | CA1305704C 8-azaxanthines alkylaminoalkyl or heterocyclyalkyl-substituted on the triazole ring, the salts thereof which are physiologicallyacceptable, their pharmaceutical compositions having antibronchospastic activity, and the process for preparing the same |
| 07/25/1992 | CA2059380A1 Endothelin receptor antagonists isolated from microbispora |
| 07/23/1992 | CA2059741A1 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept¬b|indole |
| 07/22/1992 | EP0495721A1 Use of a polypeptide having human interleukin-2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax |
| 07/22/1992 | EP0495473A1 New diazepines substituted in position 6, process for their production and their use as drugs |
| 07/22/1992 | EP0494914A1 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof |
| 07/21/1992 | US5132307 Cardiovascular disorders, hypotensive agents |
| 07/21/1992 | US5132300 Beta-lactam elastase inhibitors |
| 07/21/1992 | US5132116 Constant, long-term release of active agent; sieving and mixing swelling agent, diluent and active agent; adding lubricant and mixing; compressing in rotary production machine |
| 07/21/1992 | CA1305478C Naphthyridine and pyridopyrazine compounds and pharmaceutical usage thereof |
| 07/21/1992 | CA1305423C Pharmaceutical preparations for topical application, processes for theirmanufacture, and their use |
| 07/18/1992 | CA2059512A1 Use of polypeptide having human interleucine 2 activity for the preparation of pharmaceutical compositions useful in the treatment of pneumothorax |
| 07/17/1992 | CA2059353A1 Diazepines substituted in the 6-position, processes for their preparation and their preparation and their use as pharmaceutical compositions |
| 07/16/1992 | CA2058254A1 Benzodioxole derivatives |
| 07/15/1992 | EP0494621A1 Substituted alkenoic acid and its derivatives |
| 07/15/1992 | EP0494405A2 Use of thiazolidine-4-carboxylate derivatives for the treatment of pulmonary diseases |
| 07/15/1992 | EP0340270B1 5-ht 3? receptor antagonists for treatment of cough and bronchoconstriction |
| 07/15/1992 | CN1017425B Process for the preparation of heterocyclic amide derivatives |
| 07/14/1992 | US5130485 N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents |
| 07/14/1992 | US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals |
| 07/14/1992 | CA1305150C Derivatives of spiro (4,5) decane, process for their preparation and pharmaceutical compositions containing the same |
| 07/11/1992 | CA2058884A1 Substituted alkenoic acid and its derivatives |
| 07/11/1992 | CA2058793A1 Method for treatment for pulmonary disease |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011010A1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 07/09/1992 | CA2098917A1 New 3,4-dihydroisoquinoline derivatives and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 07/08/1992 | EP0494071A2 Trifluoromethylketone tripeptide derivatives |
| 07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
| 07/08/1992 | EP0309519B1 Pharmaceutical compositions containing pentamidine |
| 07/07/1992 | US5128447 Synthetic peptide antagonists of neurokinin a, salts thereof and respective preparation processes |
| 07/07/1992 | US5128369 Arylalkylamine derivatives |
| 07/07/1992 | US5128351 Bis-aryl amide and urea antagonists of platelet activating factor |
| 07/07/1992 | US5128338 Cardiovascular disorders |
| 07/07/1992 | US5128324 Transdermally applicable pharmaceutical preparations with sterolines and/or spiroketalines |
| 07/01/1992 | EP0493048A1 The process for the preparation of enantiomerically pure thienopyran derivative |
| 07/01/1992 | EP0492214A2 Human Interleukin-5 receptor |
| 07/01/1992 | CN1062291A Pharmaceutical agents |
| 06/30/1992 | US5126375 Asthma, chronic bronchitis |
| 06/30/1992 | US5126368 Octenoic acid derivatives useful as thromboxane A2 inhibitors |
| 06/30/1992 | CA1304391C Lipoxygenase inhibiting compounds |
| 06/29/1992 | WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters |
| 06/28/1992 | CA2058003A1 Human-interleukin-5 receptor |
| 06/25/1992 | WO1992010498A1 Novel csaids |
| 06/25/1992 | DE4041482A1 Neue pharmazeutische verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine New pharmaceutical use carbocyclic and heterocyclic fused-dihydropyridines |
| 06/24/1992 | EP0491032A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 06/23/1992 | US5124455 Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
| 06/23/1992 | US5124342 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
| 06/23/1992 | US5124336 Azabenzimidazole derivatives which are thromboxane receptor antagonists |
| 06/22/1992 | CA2058148A1 Process for the preparation of enantiomerically pure thienopyran derivative |
| 06/20/1992 | WO1992011236A1 Aerosol formulations |
| 06/20/1992 | CA2098298A1 Aerosol formulations |
| 06/17/1992 | EP0490823A1 Dihydro-isoquinoline derivates |
| 06/17/1992 | EP0490649A1 A physical form of N-[4-[5-(cyclopentyloxycarbonylamino)-1-methyl-indol-3-ylmethyl]-3-methoxybenzoyl]-2-methylbenzenesulfonamide, a process for its preparation and pharmaceutical compositions containing it |
| 06/17/1992 | EP0490648A1 Pharmaceutical agents |
| 06/17/1992 | EP0490379A2 Diamino acid derivatives and pharmaceutical compositions |
| 06/17/1992 | EP0489831A1 Substituted quinolines, their preparation and their use as lipoxygenase inhibitors and/or leukotriene antagonists |
| 06/17/1992 | EP0259499B1 Anti-allergic agent |
| 06/16/1992 | CA1303619C Alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same |
| 06/14/1992 | WO1992010190A1 Novel csaids |
| 06/14/1992 | CA2098177A1 Csaids |
| 06/14/1992 | CA2057601A1 Pharmaceutical use of diamino acid derivatives |
| 06/14/1992 | CA2057524A1 Dihydro-isoquinoline derivatives |
| 06/11/1992 | WO1992009567A1 Anti-inflammatory compounds |
| 06/11/1992 | WO1992009557A1 Benzenedimethanol suitable for micronisation |
| 06/10/1992 | EP0489548A1 A process for the preparation of 2(R)-methyl-4,4,4-trifluorobutylamine, intermediates, and a process for the preparation of a derivative thereof |
| 06/10/1992 | EP0489547A1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof |
| 06/10/1992 | EP0489327A1 Chroman derivatives |
| 06/10/1992 | EP0489300A2 Tetralones with pharmacological activity |
| 06/10/1992 | EP0489058A1 Cystic fibrosis gene |
| 06/09/1992 | US5120749 Treatment of anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellulosr immunity, parturtition, fetal lung maturation, and cellular differentiation |
| 06/09/1992 | US5120744 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
| 06/09/1992 | CA1303294C .alpha.-HYDROXY THIOETHERS |
| 06/09/1992 | CA1303057C P-aminophenols, derivatives thereof and method of use |
| 06/09/1992 | CA1303049C 3-(1h-tetrazol-5-yl)oxanilic acid and salts thereof, method for preparing the same and pharmaceutical compositions containing the compound |